✦ LIBER ✦

Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy

✍ Scribed by Meg R. Gerstenblith; Ashley K. Antony; Jacqueline M. Junkins-Hopkins; Rachel Abuav

Book ID: 116587930
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 295 KB
Volume: 66
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2010.12.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extensive eczematous reaction and dyshid

Extensive eczematous reaction and dyshidrotic lesions following intravenous immunoglobulin therapy

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Complement consumption associated with e

Complement consumption associated with eczematous cutaneous reaction during infusions of high doses of intravenous immunoglobulin

✍ E. Sarmiento; D. Micheloud; J. Carbone 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Adverse events associated with intraveno

Adverse events associated with intravenous immunoglobulin therapy

✍ David J. Hamrock 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Hematologic toxicities associated with i

Hematologic toxicities associated with intravenous immunoglobulin therapy

✍ Allison Baxley; Mojtaba Akhtari 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Hemolytic anemia associated with intrave

Hemolytic anemia associated with intravenous immunoglobulin

✍ John R. Wilson; Nirmala Bhoopalam; Morris Fisher 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Intravenous immunoglobulin (IVIg) is a useful tool in the treatment of a variety of neuromuscular disorders. Though IVIg therapy is generally safe, hemolytic anemia is a potentially serious complication that is often overlooked, and is currently not listed in product inserts. We analyzed 45 patients

Intravenous immunoglobulin therapy in sy

Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia

✍ William P. Maier; David S. Gordon; Robert F. Howard; Mansoor N. Saleh; Stephen B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Seven patients with thrombocytopenia and systemic lupus erythematosus were treated with intravenous (IV) doses of human immunoglobulin to assess clinical response and to examine the mechanism of action of IV immunoglobulin in these patients. Five of 7 patients had a >50% increase in their platelet c